# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-19-005537
Filing Date
2019-04-01
Accepted
2019-04-01 17:12:05
Documents
82
Period of Report
2018-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | f10k2018_wizepharmainc.htm | 10-K | 1642569
2 | MEMORANDUM OF UNDERSTANDING BETWEEN WIZE PHARMA LTD. AND RESDEVCO, RESEARCH AND | f10k2018ex10-57_wizepharma.htm | EX-10.57 | 8552
3 | CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | f10k2018ex23-1_wizephara.htm | EX-23.1 | 3949
4 | CERTIFICATION | f10k2018ex31-1_wizepharma.htm | EX-31.1 | 14109
5 | CERTIFICATION | f10k2018ex31-2_wizepharma.htm | EX-31.2 | 13025
6 | CERTIFICATION | f10k2018ex32-1_wizepharma.htm | EX-32.1 | 6778
7 | CERTIFICATION | f10k2018ex32-2_wizepharma.htm | EX-32.2 | 6907
8 | GRAPHIC | img_01.jpg | GRAPHIC | 12438
15 | GRAPHIC | ex23-1_001.jpg | GRAPHIC | 16305
| Complete submission text file | 0001213900-19-005537.txt |  | 6564718

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL INSTANCE FILE | wizp-20181231.xml | EX-101.INS | 1180318
10 | XBRL SCHEMA FILE | wizp-20181231.xsd | EX-101.SCH | 64786
11 | XBRL CALCULATION FILE | wizp-20181231_cal.xml | EX-101.CAL | 25197
12 | XBRL DEFINITION FILE | wizp-20181231_def.xml | EX-101.DEF | 177209
13 | XBRL LABEL FILE | wizp-20181231_lab.xml | EX-101.LAB | 513868
14 | XBRL PRESENTATION FILE | wizp-20181231_pre.xml | EX-101.PRE | 345765

Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52545 | Film No.: 19721739
SIC: 2834 Pharmaceutical Preparations